Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LY2109761 |
Synonyms | |
Therapy Description |
LY2109761 is a pan-TGFBR inhibitor, which prevents downstream signaling and may block proliferation and migration in cancer cells (PMID: 18413796, PMID: 32531714). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
LY2109761 | LY-2109761|LY 2109761 | TGFBR inhibitor (pan) 2 | LY2109761 is a pan-TGFBR inhibitor, which prevents downstream signaling and may block proliferation and migration in cancer cells (PMID: 18413796, PMID: 32531714). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|